Moreover, HMGB1 has been implicated in the pathogenesis of cognitive impairments across a spectrum of neurological conditions, including epileptic disorders, Alzheimer’s disease, and various other neurodegenerative processes (Yang et al., 2015; Paudel et al., 2019). Here, HMGB1 is linked to early-onset autosomal dominant Alzheimer disease.